Skip to main content

UBS Group AG

Position in TLSI — TriSalus Life Sciences, Inc.

CIK 1610520 ZURICH, V8

Position in TLSI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,014,863
+$696,655 QoQ
Shares Held
223,047
+180.4% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 83 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLSI Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,667,439,641 across 136 Medical Devices names. TLSI ranks #64 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TLSI

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,014,863 223,047
2026-03-31 $318,208 79,552
2025-12-31 $35,939 5,149
2025-09-30 $41,747 8,978
2025-06-30 $90,971 16,692
2025-03-31 $37,585 6,809
2024-12-31 $110 22
2024-09-30 $101 22
2024-06-30 $10,973 1,988
2024-03-31 $3,811 391
2023-12-31 $142,085 16,815
2023-09-30 $127,651 24,932
2023-06-30 MTAC 22
2023-03-31 MTAC 112
2022-12-31 MTAC 2,059
2022-09-30 MTAC 22
2022-06-30 MTAC 24,817
2022-03-31 MTAC 123
2021-12-31 MTAC 1,452
2021-09-30 MTAC 6
2021-06-30 MTAC 1,149
2021-03-31 MTAC 17